In a recent publication in The Journal of Allergy and Clinical Immunology, researchers analyzed asthma outcomes after patients stepped down their daily asthma medicines.
The main findings of the study were that for those who have had “Stable” asthma for at least 1 year, stepping down asthma medicines appears to be as safe as maintaining the same level of medicines. Very small percentage (only 11%) had problems with their step down approach in 4-5 months post reduction of medication. The patients who stepped down their asthma medicines, also saved an average of $34 each month compared to those who maintained the same level of medicines.
A great way for asthma patients who have been stable for at least 1 year on daily asthma medicine is to discuss the “Step down” approach with their doctor and along with a peak flow meter to monitor their respiratory status should be able to safely reduce their daily asthma medicines.